Company news

AstraZeneca PLC news in 2024

AstraZeneca PLC's news releases, calls and decks from 2024, newest first.

View company

EMA validates Dato-DXd MAAs for NSQ NSCLC and BC

March 4, 2024

Voydeya recommended for EU approval

February 26, 2024

Acquisition of Gracell completed

February 22, 2024

AstraZeneca prices a $5bn bond offering

February 22, 2024

AstraZeneca completes acquisition of Icosavax

February 19, 2024

Tagrisso plus chemo approved in US for lung cancer

February 19, 2024

FDA accepts Dato-DXd BLA for nonsquamous NSCLC

February 19, 2024

Tagrisso improved PFS in Stage III lung cancer

February 19, 2024

← Newer news releases

Calls in 2024

Decks in 2024